BOSTON & SPRINGFIELD, Mass.--(BUSINESS WIRE)--Massachusetts Mutual Life Insurance Company (MassMutual) today announced that it is enabling eligible policyowners to gain knowledge about their health through a variety of tools, offerings and research so they can make informed, proactive health decisions that may help them lead longer, healthier lives..

马萨诸塞州波士顿和斯普林菲尔德（BUSINESS WIRE）-马萨诸塞州共同人寿保险公司（MassMutual）今天宣布，它使符合条件的投保人能够通过各种工具，产品和研究获得有关其健康的知识，以便他们能够做出明智的，积极的健康决策，可以帮助他们度过更长，更健康的生活。。

The company’s efforts are centralized under the MassMutual Health and Wellness Program, which focuses on initiatives that provide policyowners with insights into their potential health risks, empowering them to seek out appropriate interventions and motivate healthy behaviors and lifestyles.

公司的努力集中在MassMutual健康与健康计划下，该计划侧重于为决策者提供有关其潜在健康风险的见解的举措，使他们能够寻求适当的干预措施并激励健康的行为和生活方式。

'For generations, MassMutual has delivered long-term value to our policyowners by providing holistic financial solutions that address their needs at each stage of life,” said Sears Merritt, Head of Enterprise Technology and Experience, MassMutual. “Now, we are proud to expand on our offerings by unveiling innovative solutions that provide them with knowledge to make choices that support their well-being, helping them to lead fulfilled lives and be there for the most meaningful moments with their loved ones.”.

MassMuture企业技术和经验负责人Sears Merritt说：“几代人来，MassMuture通过提供全面的财务解决方案，满足他们在生活各个阶段的需求，为我们的决策者提供了长期价值。“现在，我们很自豪地扩展我们的产品，推出创新的解决方案，为他们提供知识，做出支持他们福祉的选择，帮助他们过上充实的生活，并与亲人在一起度过最有意义的时刻。”。

Examples of MassMutual Health and Wellness Program offerings that were launched over the past year include:

去年推出的全民健康和保健计划产品的例子包括：

A research collaboration with Genomics plc – Eligible policyowners were offered a genetic risk assessment service that provided information about their likelihood of developing three common diseases, including diabetes, heart disease and certain cancers. Among more than 1,400 policyowners who participated:.

与符合Genomics plc资格的投保人进行的研究合作提供了遗传风险评估服务，该服务提供了有关他们患上三种常见疾病（包括糖尿病，心脏病和某些癌症）的可能性的信息。参与的1400多名政策所有者中：。

1 in 5 learned they may be at higher risk for preventable diseases.

1/5了解到他们可能面临更高的可预防疾病风险。

71 percent planned to take preventative action, such as physician-recommended diagnostic tests and health and lifestyle modifications.

71%计划采取预防措施，如医生推荐的诊断测试和健康及生活方式的改变。

Reported health care visits within four months of the test doubled if a high-risk result was received.

如果收到高风险结果，则在测试后四个月内报告的医疗保健访问量翻了一番。

Due to the interest demonstrated during the initial research collaboration, MassMutual will expand availability to additional policyowners this fall, continuing as the first life insurance carrier to provide the offering. The expanded service will also assess individuals’ risk levels for additional diseases including atrial fibrillation, hypercholesterolemia, hypertension and osteopenia/osteoporosis..

由于初步研究合作期间表现出的兴趣，MassMutual将于今年秋季扩大其他投保人的可用性，继续作为第一家提供该产品的人寿保险公司。扩大的服务还将评估个人对其他疾病的风险水平，包括心房颤动，高胆固醇血症，高血压和骨质减少/骨质疏松症。。

A pilot with GRAIL, LLC – Eligible policyowners were provided with access to multi-cancer early detection testing. GRAIL’s Galleri® test can detect a shared cancer signal across more than 50 types of cancer, including several for which no other form of screening is available. It can also predict the cancer signal origin, or the tissue or organ where the cancer signal originated, to help guide diagnostic evaluation.

为符合GRAIL，LLC资格的投保人提供了多癌症早期检测测试的机会。GRAIL的Galleri®测试可以检测超过50种癌症的共同癌症信号，其中包括几种没有其他形式筛查可用的癌症信号。它还可以预测癌症信号的起源，或癌症信号起源的组织或器官，以帮助指导诊断评估。

Of more than 2,200 policyowners who participated in the pilot:.

参与试点的2200多名投保人中：。

Nearly two dozen positive cancer signals were detected; confirmed cases are being determined as individuals work with their medical providers.

检测到近二十个阳性癌症信号；当个人与其医疗服务提供者合作时，正在确定确诊病例。

94 percent of participating policyowners indicated a positive overall experience with their testing.

94%的参与投保人表示他们的测试总体经验积极。

Based on the positive experience reported by policyowners who chose to participate in the pilot, MassMutual is considering a possible expansion.

根据选择参加试点的政策制定者报告的积极经验，MassMutual正在考虑可能的扩张。

MassMutual is also debuting exploratory initiatives that incentivize and reward healthy behaviors utilizing data from wearable devices:

MassMutual还推出探索性举措，利用可穿戴设备的数据激励和奖励健康行为：

The MassMutual Wellness-Enhanced Lifestyle & Longevity (WELL) Rider pilot – This optional offering from MassMutual gives new term life insurance policyowners the opportunity to earn rewards for healthy behaviors. By voluntarily tracking and reporting their physical activity and sleep data utilizing a wearable device through the LivingWELL by MassMutual app and meeting associated goals, participants can receive cash incentives of up to 5% of their annual policy premiums.

MassMutual Healthness增强生活方式和长寿（WELL）骑手试点-MassMutual提供的这项可选产品为新任期人寿保险投保人提供了获得健康行为奖励的机会。通过MassMutual app通过LivingWELL自愿跟踪和报告他们的身体活动和睡眠数据，并实现相关目标，参与者可以获得高达其年度政策保费5%的现金奖励。

The WELL Rider, launched in September, is initially available in 22 states..

9月推出的搭便车最初在22个州上市。。

The Lived Experiences Measured Using Rings Study (LEMURS) – MassMutual partnered with researchers at the University of Vermont (UVM) to explore lifestyle practices that impacted the health and wellness of more than 600 student volunteers, leveraging data from a ring that tracks movement and sleep data.

使用戒指研究（LEMURS）-MassMutual与佛蒙特大学（UVM）的研究人员合作，探索影响600多名学生志愿者健康和健康的生活方式，利用跟踪运动和睡眠的戒指数据。

Findings advanced MassMutual’s understanding of the correlation between well-being markers such as exercise, respiratory rate during sleep, group therapy and time spent in nature that were shown to have significant impact on reducing levels of stress and anxiety in college students. Among key findings, respiratory rate was shown to be significantly associated with stress during the first semester of college for participating students..

研究结果提高了MassMutual对健康标志物之间相关性的理解，如运动，睡眠期间的呼吸频率，团体治疗和在自然界中花费的时间，这些标志物对降低大学生的压力和焦虑水平有显着影响。在主要研究结果中，参与学生大学第一学期的呼吸频率与压力显着相关。。

“We know that individuals increasingly want to take charge of their health and well-being so they can live their best lives,” said Merritt. “As a mutual company that operates for the benefit of our policyowners, we are focused on not only helping people secure their future and protect the ones they love, but also supporting their overall quality and length of life.”.

美利特说：“我们知道，个人越来越想要负责他们的健康和福祉，以便他们能够过上最好的生活。”。“作为一家为我们的投保人服务的共同公司，我们的重点不仅在于帮助人们确保自己的未来并保护他们所爱的，还在于支持他们的整体质量和寿命。”。

The MassMutual Health and Wellness Program employs a test and learn approach, with potential for future offerings to be launched and others to be concluded depending on policyowner interest and learnings.

MassMutual Health and Wellness计划采用测试和学习方法，有可能推出未来产品，并根据政策所有者的兴趣和学习情况总结其他产品。

Participation in MassMutual Health and Wellness Program initiatives is voluntary. Results do not impact policyowners’ current policies or premiums. MassMutual only receives high-level, anonymized data from the Genomics and GRAIL offerings and leverages policyowner information strictly to facilitate providing benefits associated with using the LivingWELL by MassMutual app.

参与MassMutual健康和保健计划举措是自愿的。结果不会影响投保人目前的政策或保费。MassMuture仅接收来自Genomics和GRAIL产品的高级匿名数据，并严格利用政策所有者信息来促进MassMutual应用程序提供与使用LivingWELL相关的好处。

UVM does not provide MassMutual with any LEMURS participant information. Anonymized, aggregate data allows the company to better understand policyowners’ health and behaviors as well as their interest in these types of offerings. Eligibility is based on factors including age, geography, and type of individual MassMutual policy..

UVM不提供任何LEMURS参与者信息的MassMutual。匿名聚合数据使公司能够更好地了解投保人的健康和行为以及他们对这些类型产品的兴趣。资格取决于年龄，地理位置和个人集体政策类型等因素。。

About MassMutual

万通

MassMutual is a leading mutual life insurance company that is run for the benefit of its members and participating policyowners. Founded in 1851, the company has been continually guided by one consistent purpose: we help people secure their future and protect the ones they love. With a focus on delivering long-term value, MassMutual offers a wide range of protection, accumulation, wealth management and retirement products and services.

MassMutual是一家领先的共同人寿保险公司，为其成员和参与的投保人带来利益。该公司成立于1851年，一直以一个一致的目标为指导：我们帮助人们确保自己的未来并保护他们所爱的目标。MassMuture专注于提供长期价值，提供广泛的保护，积累，财富管理和退休产品和服务。

For more information, visit www.massmutual.com..

欲了解更多信息，请访问www.massmutual.com。。

About Genomics plc

关于基因组学plc

Genomics plc is a pioneering healthcare company that aims to transform health through the power of genomics. In 2014, Professor Sir Peter Donnelly and three colleagues founded Genomics plc, spinning it out of the University of Oxford, with Peter becoming CEO in 2017. The company, which now employs over 100 people in the UK and the US, has an extensive data platform and cutting-edge analytical technology to enable prevention-first approaches to individual and population health.

Genomics plc是一家开拓性的医疗保健公司，旨在通过基因组学的力量改变健康状况。2014年，Peter Donnelly爵士和三位同事创立了Genomics plc，将其从牛津大学推出，Peter于2017年成为首席执行官。该公司现在在英国和美国雇用100多万人，拥有广泛的数据平台和尖端的分析技术，可以为个人和人口健康提供预防优先的方法。

Genomics' powerful risk prediction tools can get more of the right people into the appropriate screening, diagnosis, and treatment pathways they need. Genomics’ core technology also supports the life sciences sector in the successful discovery and validation of new drug targets, improved clinical trial design and efficiency, and the development of novel companion diagnostics..

基因组学强大的风险预测工具可以让更多合适的人进入他们需要的适当的筛查，诊断和治疗途径。基因组学的核心技术还支持生命科学领域成功发现和验证新药靶标，改进临床试验设计和效率，以及开发新型伴侣诊断。。

About GRAIL

关于GRAIL

GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by developing pioneering technology to detect and identify multiple deadly cancer types early. The company is using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art computer science and data science to enhance the scientific understanding of cancer biology, and to develop its multi-cancer early detection blood test.

GRAIL是一家医疗保健公司，其使命是在癌症治愈的时候尽早发现癌症。GRAIL致力于通过开发开创性技术来减轻全球癌症负担，以便及早发现和识别多种致命的癌症类型。该公司正在利用新一代测序，人口规模临床研究和最先进的计算机科学和数据科学的力量，加强对癌症生物学的科学理解，并开发其多癌症早期检测血液测试。

GRAIL is headquartered in Menlo Park, CA with locations in Washington, D.C., North Carolina, and the United Kingdom. GRAIL, LLC, is a subsidiary of Illumina, Inc. (NASDAQ:ILMN) currently held separate from Illumina Inc. under the terms of the Interim Measures Order of the European Commission..

GRAIL总部设在加利福尼亚州门洛帕克，位于华盛顿特区，北卡罗来纳州和英国。GRAIL，LLC是Illumina，Inc。（纳斯达克股票代码：ILMN）的子公司，目前根据欧盟委员会临时措施命令的条款与Illumina Inc.分开持有。。

For more information, visit grail.com.

欲了解更多信息，请访问grail.com。

About UVM

关于UVM

Since 1791, the University of Vermont has worked to move humankind forward. UVM’s strengths align with the most pressing needs of our time: the health of our societies and the health of our environment. Our size—large enough to offer a breadth of ideas, resources, and opportunities, yet intimate enough to enable close faculty-student mentorship across all levels of study—allows us to pursue these interconnected issues through cross-disciplinary research and collaboration.

自1791年以来，佛蒙特大学一直致力于推动人类前进。UVM的优势符合我们这个时代最紧迫的需求：我们社会的健康和环境的健康。我们的规模足以提供广泛的想法，资源和机会，但足够亲密，能够在各级研究中实现密切的教师-学生指导，使我们能够通过跨学科研究和合作来追求这些相互关联的问题。

Providing an unparalleled educational experience for our students, and ensuring their success, are at the core of what we do. As one of the nation’s first land grant universities, UVM advances Vermont and the broader society through the discovery and application of new knowledge. UVM is derived from the Latin Universitas Viridis Montis (in English, University of the Green Mountains)..

为我们的学生提供无与伦比的教育经验，确保他们的成功，是我们所做的核心。作为全国第一批土地补助大学之一，UVM通过发现和应用新知识，推动佛蒙特州和更广泛的社会。UVM来源于拉丁语Universitas Viridis Montis（英语，绿色山脉大学）。。